Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-96-000643
Filing Date
1996-02-14
Accepted
1996-02-14 00:00:00
Documents
6
Period of Report
1995-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q 10-Q 31357
2 AMENDATORY AGREEMENT EX-10.1 6675
3 COLLABORATIVE RESEARCH AGREEMENT W/AHP EX-10.2 96134
4 COLLABORATIVE RESEARCH AGREEMENT W/ HOECHST AKT. EX-10.3 75331
5 COLLABORATIVE RESEARCH AGREEMENT W/HOECHST ROUSSEL EX-10.4 47475
6 FINANCIAL DATA SCHEDULE EX-27 2150
  Complete submission text file 0000950123-96-000643.txt   261134
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
ONCOGENE SCIENCE INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-15190 | Film No.: 96520272
SIC: 2835 In Vitro & In Vivo Diagnostic Substances